Monogram Technologies Set to Showcase Innovations at the 37th Annual Roth Conference

Monogram Technologies to Present at 37th Annual ROTH Conference

Austin, TX, March 5, 2025 – Monogram Technologies Inc. (NASDAQ: MGRM), a leading AI-driven robotics company specializing in enhancing human health through an initial focus on orthopedic surgery, announced that its Chief Executive Officer, Ben Sexson, and Chief Financial Officer, Noel Knape, will attend the 37th Annual ROTH Conference. This event will take place at the Laguna Cliffs Marriott Resort & Spa in Dana Point, CA from March 16-18, 2025.

Company Leaders to Share Insights on Monogram’s Innovative Approach to Orthopedic Surgery

During the conference, Monogram’s executives will engage in one-on-one meetings with institutional investors and provide updates on the company’s latest advancements in AI-driven robotics for orthopedic procedures. The presentations will focus on Monogram’s mission to revolutionize the healthcare sector by combining advanced robotics and artificial intelligence to improve surgical outcomes and reduce recovery time for patients.

Impact on Individual Investors

  • Opportunity to learn about Monogram’s innovative technology and growth strategy
  • One-on-one access to Monogram’s management team to ask questions and gather insights
  • Potential for increased investment opportunities in Monogram Technologies

Global Implications

  • Advancements in AI-driven robotics for orthopedic surgery could lead to more efficient and precise surgical procedures
  • Reduced recovery time and improved patient outcomes could lead to cost savings for healthcare systems
  • Monogram’s technology could set a new standard for the future of surgical procedures, potentially disrupting traditional methods and creating new opportunities for growth

Conclusion

Monogram Technologies’ participation in the 37th Annual ROTH Conference marks an exciting opportunity for investors to engage with the company’s leadership and learn about its groundbreaking AI-driven robotics technology for orthopedic surgery. The potential implications for individuals and the global healthcare sector are significant, with the potential for more efficient, precise, and cost-effective surgical procedures. Stay tuned for updates on Monogram’s progress and innovations in the field of orthopedic robotics.

Monogram Technologies continues to push the boundaries of what is possible in healthcare through the application of advanced robotics and artificial intelligence. The company’s commitment to improving human health and revolutionizing the surgical landscape makes it an exciting investment opportunity and a potential game-changer for the future of healthcare. Join us in following Monogram’s journey as it paves the way for a more efficient, precise, and cost-effective healthcare system.

Leave a Reply